Literature DB >> 20571484

Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.

Francis Rodriguez Bambico1, Tommaso Cassano, Sergio Dominguez-Lopez, Noam Katz, Claire Dominique Walker, Daniele Piomelli, Gabriella Gobbi.   

Abstract

Pharmacological blockade of the anandamide-degrading enzyme, fatty acid amide hydrolase (FAAH), produces CB(1) receptor (CB(1)R)-mediated analgesic, anxiolytic-like and antidepressant-like effects in murids. Using behavioral and electrophysiological approaches, we have characterized the emotional phenotype and serotonergic (5-HT) activity of mice lacking the FAAH gene in comparison to their wild type counterparts, and their response to a challenge of the CB(1)R antagonist, rimonabant. FAAH null-mutant (FAAH(-/-)) mice exhibited reduced immobility in the forced swim and tail suspension tests, predictive of antidepressant activity, which was attenuated by rimonabant. FAAH(-/-) mice showed an increase in the duration of open arm visits in the elevated plus maze, and a decrease in thigmotaxis and an increase in exploratory rearing displayed in the open field, indicating anxiolytic-like effects that were reversed by rimonabant. Rimonabant also prolonged the initiation of feeding in the novelty-suppressed feeding test. Electrophysiological recordings revealed a marked 34.68% increase in dorsal raphe 5-HT neural firing that was reversed by rimonabant in a subset of neurons exhibiting high firing rates (33.15% mean decrease). The response of the prefrontocortical pyramidal cells to the 5-HT(2A/2C) agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane ((+/-)-DOI) revealed desensitized 5-HT(2A/2C) receptors, likely linked to the observed anxiolytic-like behaviors. The hippocampal pyramidal response to the 5-HT(1A) antagonist, WAY-100635, indicates enhanced tonus on the hippocampal 5-HT(1A) heteroreceptors, a hallmark of antidepressant-like action. Together, these results suggest that FAAH genetic deletion enhances anxiolytic-like and antidepressant-like effects, paralleled by altered 5-HT transmission and postsynaptic 5-HT(1A) and 5-HT(2A/2C) receptor function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571484      PMCID: PMC3055302          DOI: 10.1038/npp.2010.80

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  100 in total

1.  5HT2 receptors, depression and anxiety.

Authors:  J F Deakin
Journal:  Pharmacol Biochem Behav       Date:  1988-04       Impact factor: 3.533

2.  Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.

Authors:  E Hollander; C DeCaria; R Gully; A Nitescu; R F Suckow; J M Gorman; D F Klein; M R Liebowitz
Journal:  Psychiatry Res       Date:  1991-01       Impact factor: 3.222

3.  Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.

Authors:  C R Ashby; L H Jiang; R J Kasser; R Y Wang
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

4.  Desensitization of the neuronal 5-HT carrier following its long-term blockade.

Authors:  G Piñeyro; P Blier; T Dennis; C de Montigny
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

5.  The effects of chronic antidepressant treatment in an animal model of anxiety.

Authors:  S R Bodnoff; B Suranyi-Cadotte; D H Aitken; R Quirion; M J Meaney
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.

Authors:  G A Kennett; S Lightowler; V de Biasi; N C Stevens; M D Wood; I F Tulloch; T P Blackburn
Journal:  Neuropharmacology       Date:  1994-12       Impact factor: 5.250

7.  Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.

Authors:  G A Kennett; K Pittaway; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

8.  The tail suspension test: a new method for screening antidepressants in mice.

Authors:  L Steru; R Chermat; B Thierry; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex.

Authors:  L Rägo; R A Kiivet; J Harro; M Pŏld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

10.  Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

Authors:  S Pellow; S E File
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

View more
  36 in total

1.  Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure.

Authors:  M N Hill; S A Kumar; S B Filipski; M Iverson; K L Stuhr; J M Keith; B F Cravatt; C J Hillard; S Chattarji; B S McEwen
Journal:  Mol Psychiatry       Date:  2012-07-10       Impact factor: 15.992

2.  Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.

Authors:  Maria Morena; Robert J Aukema; Kira D Leitl; Asim J Rashid; Haley A Vecchiarelli; Sheena A Josselyn; Matthew N Hill
Journal:  J Neurosci       Date:  2018-12-20       Impact factor: 6.167

Review 3.  Monoacylglycerol lipase - a target for drug development?

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 4.  Modulation of the serotonin system by endocannabinoid signaling.

Authors:  Samir Haj-Dahmane; Roh-Yu Shen
Journal:  Neuropharmacology       Date:  2011-02-24       Impact factor: 5.250

5.  Synthesis and preclinical evaluation of [¹⁸F]FCHC for neuroimaging of fatty acid amide hydrolase.

Authors:  Timothy M Shoup; Ali A Bonab; Alan A Wilson; Neil Vasdev
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

6.  Exposure to an enriched environment accelerates recovery from cerebellar lesion.

Authors:  Francesca Foti; Daniela Laricchiuta; Debora Cutuli; Paola De Bartolo; Francesca Gelfo; Francesco Angelucci; Laura Petrosini
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

7.  Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation.

Authors:  Brian C Shonesy; Rebecca J Bluett; Teniel S Ramikie; Rita Báldi; Daniel J Hermanson; Philip J Kingsley; Lawrence J Marnett; Danny G Winder; Roger J Colbran; Sachin Patel
Journal:  Cell Rep       Date:  2014-11-26       Impact factor: 9.423

8.  Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway.

Authors:  Ryan J McLaughlin; Matthew N Hill; Francis R Bambico; Kara L Stuhr; Gabriella Gobbi; Cecilia J Hillard; Boris B Gorzalka
Journal:  Eur Neuropsychopharmacol       Date:  2012-02-10       Impact factor: 4.600

9.  Emotional regulatory function of receptor interacting protein 140 revealed in the ventromedial hypothalamus.

Authors:  S Flaisher-Grinberg; H C Tsai; X Feng; L N Wei
Journal:  Brain Behav Immun       Date:  2014-04-13       Impact factor: 7.217

Review 10.  Endocannabinoid signaling in the etiology and treatment of major depressive illness.

Authors:  Cecilia J Hillard; Qing-song Liu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.